SCHEMBL3963446

SCHEMBL3963446

Cc1[nH]c(=O)c(Nc2ccc(C(=O)N3CCOCC3)cn2)cc1-c1cc(F)cc(NC(=O)c2ccc(C(C)(C)C)cc2)c1C

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
BTK Q06187 19/20 0.60
CLK2 P49760 1/20 0.53
JAK2 O60674 1/20 0.45
INSR P06213 1/20 0.45
IGF1R P08069 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C8 P10632 1/20 0.45
CYP2C9 P11712 1/20 0.45
SRC P12931 1/20 0.45
CYP2C19 P33261 1/20 0.45
FLT3 P36888 1/20 0.45
TEC P42680 1/20 0.45
TXK P42681 1/20 0.45
MAPKAPK2 P49137 1/20 0.45
BMX P51813 1/20 0.45
JAK3 P52333 1/20 0.45
ITK Q08881 1/20 0.45
MAPKAPK3 Q16644 1/20 0.45
TYK2 P29597 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3965301 0.93 BTK (0.55) BTKCLK2TYK2
SCHEMBL3961624 0.85 BTK (0.61) BTKCLK2
SCHEMBL1322006 0.84 BTK (0.82) BTKCLK2
SCHEMBL3964890 0.80 BTK (0.61) BTKCLK2JAK2INSRIGF1R
SCHEMBL1322606 0.79 BTK (0.77) BTKCLK2JAK2INSRIGF1R
SCHEMBL1321952 0.78 BTK (0.74) BTKCLK2
SCHEMBL3655714 0.76 BTK (0.66) BTKCLK2JAK2INSRIGF1R
SCHEMBL5242071 0.76 BTK (0.66) BTKJAK2INSRIGF1RCYP3A4
SCHEMBL102343 0.75 BTK (1.00) BTKCLK2
SCHEMBL104439 0.75 BTK (0.77) BTKCLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081923-A1 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI Pharmaceuticals, Inc. (US) 2009-07-29 EP disclosed
WO-2008033854-A1 CERTAIN SUBSTITUTED AMIDES, METHOD OF MAKING, AND METHOD OF USE THEREOF CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed